Application of Shen-Gui pills in preparation of drugs for tumor inhibition and combined chemotherapy drugs
A technology of tumor cells combined with chemotherapy, applied in the direction of drug combination, anti-tumor drugs, pill delivery, etc., can solve the problems of decreased spleen index and thymus index, decreased immunity, leukopenia, etc., and increased the spleen index and thymus index. , weaken the ability to tolerate hypoxia, improve the effect of survival
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0078] The application of Shengui pills in the preparation of drugs for inhibiting tumor cells. The weight ratio of Shengui pills is 1:2, Angelica: Sophora flavescens. The medicinal form of Shengui pills is decoction, and the tumor cells are H22 liver cancer cells. The dosage of Shengui pills It is 9g per kilogram of body weight per day, and the administration method is intragastric administration, and the administration time is 14 days.
Embodiment 2
[0080] Application of Shengui Pills in the preparation of combined chemotherapy drugs for inhibiting tumor cells. The combined chemotherapy drugs are composed of Shengui Pills and cisplatin. The tumor cells are H22 liver cancer cells. The dosage of Shengui Pills is 9g per kilogram of body weight per day. The dosage is intragastric administration for 14 days. , The medication time is 14 days.
PUM

Abstract
Description
Claims
Application Information

- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com